English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/104023
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorPacheco-Torres, Jesús-
dc.contributor.authorLópez-Larrubia, Pilar-
dc.contributor.authorNieto, Elena-
dc.contributor.authorAlajarín, Ramón-
dc.contributor.authorÁlvarez-Builla, Julio-
dc.contributor.authorBallesteros, Paloma-
dc.contributor.authorCerdán, Sebastián-
dc.identifier.citationISMRM 2013-
dc.descriptionTrabajo presentado al 21th Annual Meeting & Exhibition of International Society for Magnetic Resonance in Medicine, celebrado en Salt Lake City (US) del 20 al 26 de Abril de 2013.-
dc.description.abstractMeasurement of tumor oxygenation has gained importance in the last decades due to the known relationship between tumor hypoxia and tumor aggressiveness, poor outcome and resistance to therapies. Several techniques have been developed for this end (oxygen electrodes, EPR, PET…) but none of them has gained widespread acceptance. 2-Nitroimidazole derivatives (EF5, Pimonidzole, 18F-MISO...) have been extensively used as molecular markers of hypoxia in combination with different techniques as immunohistochemistry, PET or 19F-MRI. Here we evaluate, for the first time to our knowledge, the use of these hypoxia markers in combination with 1H-MRSI to generate oxygenation maps in vivo.-
dc.relation.isversionofPublisfer's version-
dc.title1H MRSI maps of tumor hypoxia using an extrinsic hypoxia probe-
dc.typepóster de congreso-
dc.description.versionPeer Reviewed-
Appears in Collections:(IIBM) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
1H_MRSI_Maps.pdf950,49 kBAdobe PDFThumbnail
Show simple item record

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.